BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 15036905)

  • 1. Degenerate recognition of T cell epitopes: impact of T cell receptor reserve and stability of peptide:MHC complexes.
    Ford ML; Evavold BD
    Mol Immunol; 2004 Feb; 40(14-15):1019-25. PubMed ID: 15036905
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T cell receptor crossreactivity as a general property of T cell recognition.
    Wucherpfennig KW
    Mol Immunol; 2004 Feb; 40(14-15):1009-17. PubMed ID: 15036904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. T-cell receptor triggering is critically dependent on the dimensions of its peptide-MHC ligand.
    Choudhuri K; Wiseman D; Brown MH; Gould K; van der Merwe PA
    Nature; 2005 Jul; 436(7050):578-82. PubMed ID: 16049493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two-step binding mechanism for T-cell receptor recognition of peptide MHC.
    Wu LC; Tuot DS; Lyons DS; Garcia KC; Davis MM
    Nature; 2002 Aug; 418(6897):552-6. PubMed ID: 12152083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural basis for self-recognition by autoimmune T-cell receptors.
    Yin Y; Li Y; Mariuzza RA
    Immunol Rev; 2012 Nov; 250(1):32-48. PubMed ID: 23046121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A powerful combination: the use of positional scanning libraries and biometrical analysis to identify cross-reactive T cell epitopes.
    Nino-Vasquez JJ; Allicotti G; Borras E; Wilson DB; Valmori D; Simon R; Martin R; Pinilla C
    Mol Immunol; 2004 Feb; 40(14-15):1063-74. PubMed ID: 15036911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Degenerate T-cell receptor recognition, autoreactive cells, and the autoimmune response in multiple sclerosis.
    Markovic-Plese S
    Neuroscientist; 2009 Jun; 15(3):225-31. PubMed ID: 19297658
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specificity of T-cell alloreactivity.
    Felix NJ; Allen PM
    Nat Rev Immunol; 2007 Dec; 7(12):942-53. PubMed ID: 18007679
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential contact of disparate class I/peptide complexes as the basis for epitope cross-recognition by a single T cell receptor.
    Loftus DJ; Chen Y; Covell DG; Engelhard VH; Appella E
    J Immunol; 1997 Apr; 158(8):3651-8. PubMed ID: 9103427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serial triggering of many T-cell receptors by a few peptide-MHC complexes.
    Valitutti S; Müller S; Cella M; Padovan E; Lanzavecchia A
    Nature; 1995 May; 375(6527):148-51. PubMed ID: 7753171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantifying the strength of ligand antagonism in TCR triggering.
    Van Den Berg HA; Burroughs NJ; Rand DA
    Bull Math Biol; 2002 Jul; 64(4):781-808. PubMed ID: 12216421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Specificity and degeneracy of T cells.
    Wilson DB; Wilson DH; Schroder K; Pinilla C; Blondelle S; Houghten RA; Garcia KC
    Mol Immunol; 2004 Feb; 40(14-15):1047-55. PubMed ID: 15036909
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A three-domain T cell receptor is biologically active and specifically stains cell surface MHC/peptide complexes.
    Plaksin D; Polakova K; McPhie P; Margulies DH
    J Immunol; 1997 Mar; 158(5):2218-27. PubMed ID: 9036968
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Limited plasticity in T cell recognition of modified T cell receptor contact residues in MHC class II bound peptides.
    de Haan EC; Wagenaar-Hilbers JP; Liskamp RM; Moret EE; Wauben MH
    Mol Immunol; 2005 Feb; 42(3):355-64. PubMed ID: 15589324
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The fidelity, occasional promiscuity, and versatility of T cell receptor recognition.
    Godfrey DI; Rossjohn J; McCluskey J
    Immunity; 2008 Mar; 28(3):304-14. PubMed ID: 18342005
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extraordinary cross-reactivity of an autoimmune T-cell receptor recognizing specific peptides both on autologous and on allogeneic HLA class II molecules.
    Hansen BE; Rasmussen AH; Jakobsen BK; Ryder LP; Svejgaard A
    Tissue Antigens; 2007 Jul; 70(1):42-52. PubMed ID: 17559580
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modulation of T cell function by TCR/pMHC binding kinetics.
    Carreño LJ; González PA; Kalergis AM
    Immunobiology; 2006; 211(1-2):47-64. PubMed ID: 16446170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fab antibodies capable of blocking T cells by competitive binding have the identical specificity but a higher affinity to the MHC-peptide-complex than the T cell receptor.
    Neumann F; Sturm C; Hülsmeyer M; Dauth N; Guillaume P; Luescher IF; Pfreundschuh M; Held G
    Immunol Lett; 2009 Aug; 125(2):86-92. PubMed ID: 19524620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The CDR3 regions of an immunodominant T cell receptor dictate the 'energetic landscape' of peptide-MHC recognition.
    Borg NA; Ely LK; Beddoe T; Macdonald WA; Reid HH; Clements CS; Purcell AW; Kjer-Nielsen L; Miles JJ; Burrows SR; McCluskey J; Rossjohn J
    Nat Immunol; 2005 Feb; 6(2):171-80. PubMed ID: 15640805
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interactions between CD8alphabeta and the TCRalphabeta/CD3-receptor complex.
    Rubin B; Riond J; Leghait J; Gairin JE
    Scand J Immunol; 2006 Sep; 64(3):260-70. PubMed ID: 16918695
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.